Thymic constructs and uses thereof
AssigneeThe Francis Crick Institute Limited
InventorPaola BONFANTI
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of producing a thymic construct suitable for implantation into a subject, the method comprising the steps of: (i) providing an acellular scaffold; (ii) seeding the acellular scaffold with thymic epithelial cells having mesenchymal properties; and (iii) culturing the seeded scaffold to produce said construct. The thymic epithelial cells are preferably CD49f+ and may also be VIM+, TE-7+ and/or CD90+. The invention further provides pharmaceutical compositions, uses and therapies using thymic epithelial cells having mesenchymal properties.
Claims23
A method of producing a thymic construct suitable for implantation into a subject, the method comprising the steps of:
- (i) providing an acellular scaffold;
- (ii) seeding the acellular scaffold with thymic epithelial cells having mesenchymal properties;
- and
- (iii) culturing the seeded scaffold to produce said construct.
(canceled)
(canceled)
A pharmaceutical composition comprising thymic epithelial cells having mesenchymal properties for regeneration of thymus.
A pharmaceutical composition comprising isolated thymic epithelial cells having mesenchymal properties, and a pharmaceutically acceptable carrier, and optionally further comprising isolated thymic interstitial cells.
(canceled)
Dependencies are inferred from the claim text.